Hikma Pharmaceuticals PLC Stock Price, News & Analysis (LON:HIK)

GBX 1,102 61.00 (5.86 %)
(As of 11/20/2017 04:00 PM ET)
Previous CloseGBX 1,102
Today's RangeGBX 1,113 - GBX 10.42
52-Week RangeGBX 906.50 - GBX 2,346
Volume1.11 million shs
Average Volume960,603 shs
Market Capitalization£2.5 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Hikma Pharmaceuticals PLC (LON:HIK)

Hikma Pharmaceuticals PLC logoHikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing and marketing a range of both branded and non-branded generic and in-licensed products. The Company's segments include Branded, Injectables, Generics and Others. It sells branded generics and in-licensed patented products across the Middle East and North Africa (MENA) region and other markets. The Company sells specialized generic injectable products across the globe. It also sells non-injectable generic products in the United States, supplying over 260 products in approximately 110 different dosage strengths and forms. The Company's other businesses comprise Arab Medical Containers, a manufacturer of plastic specialized medicinal sterile containers, International Pharmaceuticals Research Centre, which conducts bio-equivalency studies, and the active pharmaceutical ingredient (API) manufacturing division of Hikma Pharmaceuticals Limited Jordan.


Industry, Sector and Symbol:
  • Industry: Pharmaceuticals
  • Sub-Industry: N/A
  • Sector: Healthcare
  • Symbol: LON:HIK
  • CUSIP: N/A
  • Web: www.hikma.com
Profitability:
  • Trailing EPS: GBX 0.52
  • Net Margins: 7.82%
  • Return on Equity: 5.69%
  • Return on Assets: 3.19%
Misc:
  • Outstanding Shares: 240,660,000
 

Frequently Asked Questions for Hikma Pharmaceuticals PLC (LON:HIK)

What is Hikma Pharmaceuticals PLC's stock symbol?

Hikma Pharmaceuticals PLC trades on the London Stock Exchange (LON) under the ticker symbol "HIK."

How often does Hikma Pharmaceuticals PLC pay dividends? What is the dividend yield for Hikma Pharmaceuticals PLC?

Hikma Pharmaceuticals PLC announced a dividend on Wednesday, March 15th. Stockholders of record on Thursday, April 6th will be paid a dividend of GBX 0.22 per share on Thursday, May 25th. This represents a dividend yield of 0.78%. The ex-dividend date is Thursday, April 6th. This is a positive change from Hikma Pharmaceuticals PLC's previous dividend of $0.21. The official announcement can be accessed at this link. View Hikma Pharmaceuticals PLC's Dividend History.

Where is Hikma Pharmaceuticals PLC's stock going? Where will Hikma Pharmaceuticals PLC's stock price be in 2017?

10 Wall Street analysts have issued 12 month price targets for Hikma Pharmaceuticals PLC's stock. Their predictions range from GBX 1,000 to GBX 2,431. On average, they expect Hikma Pharmaceuticals PLC's share price to reach GBX 1,367.60 in the next year. View Analyst Ratings for Hikma Pharmaceuticals PLC.

Who are some of Hikma Pharmaceuticals PLC's key competitors?

Who are Hikma Pharmaceuticals PLC's key executives?

Hikma Pharmaceuticals PLC's management team includes the folowing people:

  • Said Darwazah, Chairman of the Board, Chief Executive
  • Mazen Samih Talib Darwazah, Executive Vice Chairman of the Board, President and Chief Executive Officer of MENA and Emerging Markets
  • Khalid Nabilsi, Chief Financial Officer
  • Brian Hoffman, President, West-Ward Pharmaceuticals
  • Michael Raya, Chief Executive Officer, West-Ward Pharmaceuticals
  • Majda Labadi, Corporate Vice President - Human Resources and Head of Operations, MENA
  • Riad Mishlawi, EU Vice President and Global Head - Injectables
  • Susan Ringdal, Vice President - Corporate Strategy and Investor Relations
  • Hussein Arkhagha, General Counsel
  • Bassam Wael Rushdi Kanaan, Chief Strategy and Corporate Development Officer

How do I buy Hikma Pharmaceuticals PLC stock?

Shares of Hikma Pharmaceuticals PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Hikma Pharmaceuticals PLC's stock price today?

One share of Hikma Pharmaceuticals PLC stock can currently be purchased for approximately GBX 1,102.

How big of a company is Hikma Pharmaceuticals PLC?

Hikma Pharmaceuticals PLC has a market capitalization of £2.5 billion.

How can I contact Hikma Pharmaceuticals PLC?

Hikma Pharmaceuticals PLC's mailing address is 1 New Burlington Place, LONDON, W1S 2HR, United Kingdom. The company can be reached via phone at +44-20-73992760.


MarketBeat Community Rating for Hikma Pharmaceuticals PLC (LON HIK)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  402 (Vote Outperform)
Underperform Votes:  199 (Vote Underperform)
Total Votes:  601
MarketBeat's community ratings are surveys of what our community members think about Hikma Pharmaceuticals PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Hikma Pharmaceuticals PLC (LON:HIK)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 7 Hold Ratings, 3 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.30)
Consensus Price Target: GBX 1,367.60

Consensus Price Target History for Hikma Pharmaceuticals PLC (LON:HIK)

Price Target History for Hikma Pharmaceuticals PLC (LON:HIK)

Analysts' Ratings History for Hikma Pharmaceuticals PLC (LON:HIK)

Show:
DateFirmActionRatingPrice TargetDetails
11/15/2017Peel HuntReiterated RatingHoldGBX 1,390View Rating Details
11/10/2017J P Morgan Chase & CoLower Price TargetNeutralGBX 1,250 -> GBX 1,000View Rating Details
11/9/2017Stifel NicolausLower Price TargetHoldGBX 1,320 -> GBX 1,000View Rating Details
11/9/2017Numis Securities LtdUpgradeBuyGBX 1,300View Rating Details
11/9/2017Jefferies Group LLCReiterated RatingHoldGBX 1,045View Rating Details
8/25/2017Barclays PLCLower Price TargetOverweightGBX 2,200 -> GBX 1,500View Rating Details
8/24/2017Citigroup Inc.Reiterated RatingNeutralGBX 1,350View Rating Details
8/22/2017Goldman Sachs Group, Inc. (The)DowngradeNeutralGBX 2,600 -> GBX 1,310View Rating Details
8/21/2017Morgan StanleyDowngradeEqual weightGBX 1,600 -> GBX 1,350View Rating Details
11/30/2016AlphaValueReiterated RatingBuyGBX 2,431View Rating Details
3/16/2016Panmure GordonUpgradeBuyGBX 2,120View Rating Details
(Data available from 11/20/2015 forward)

Earnings

Earnings History for Hikma Pharmaceuticals PLC (LON:HIK)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Hikma Pharmaceuticals PLC (LON:HIK)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History by Quarter for Hikma Pharmaceuticals PLC (LON HIK)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/15/2017€0.220.78%4/6/20174/6/20175/25/2017
3/11/2015€0.210.64%4/16/20154/16/20155/21/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Hikma Pharmaceuticals PLC (LON HIK)

Insider Trades by Quarter for Hikma Pharmaceuticals PLC (LON:HIK)

Insider Trades by Quarter for Hikma Pharmaceuticals PLC (LON HIK)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/19/2016Ali Al-HusryInsiderBuy50,000GBX 1,790£895,000
12/16/2016Mazen DarwazahInsiderBuy90,730GBX 1,849£1,677,597.70
12/12/2016Ali Al-HusryInsiderBuy50,000GBX 1,707£853,500
12/9/2016Ali Al-HusryInsiderBuy50,000GBX 1,723£861,500
12/6/2016Ali Al-HusryInsiderBuy100,000GBX 1,682£1,682,000
12/5/2016Ali Al-HusryInsiderBuy50,000GBX 1,674£837,000
12/2/2016Mazen DarwazahInsiderBuy50,000GBX 1,662£831,000
12/1/2016Mazen DarwazahInsiderBuy50,000GBX 1,674£837,000
11/30/2016Said DarwazahInsiderBuy50,000GBX 1,662£831,000
9/28/2016Said DarwazahInsiderBuy10,000GBX 2,085£208,500
9/27/2016Ali Al-HusryInsiderBuy50,000GBX 2,094£1,047,000
9/26/2016Said DarwazahInsiderBuy50,000GBX 2,078£1,039,000
9/23/2016Ali Al-HusryInsiderBuy50,000GBX 2,099£1,049,500
9/21/2016Ali Al-HusryInsiderBuy50,000GBX 2,138£1,069,000
9/16/2016Al-Husry,AliInsiderBuy50,000GBX 2,119£1,059,500
9/15/2016Darwazah,SaidInsiderBuy70,251GBX 2,122£1,490,726.22
9/8/2016Darwazah,MazenInsiderBuy150,000GBX 2,162£3,243,000
9/6/2016Darwazah,MazenInsiderBuy155,991GBX 2,194£3,422,442.54
8/31/2016Al-Husry,AliInsiderBuy140,000GBX 2,150£3,010,000
8/26/2016Darwazah,SaidInsiderBuy200,000GBX 2,160£4,320,000
6/24/2016Darwazah,MazenInsiderBuy150,000GBX 2,200£3,300,000
6/17/2016Al-Husry,AliInsiderBuy70,000GBX 22£15,400
5/9/2016Darwazah,SaidInsiderBuy17,440GBX 2,228£388,563.20
4/26/2016Darwazah,SaidInsiderBuy10,000GBX 2,260£226,000
4/25/2016Darwazah,SaidInsiderBuy10,000GBX 2,324£232,400
4/22/2016Darwazah,SaidInsiderBuy30,000GBX 2,325£697,500
4/20/2016Darwazah,SaidInsiderBuy30,000GBX 2,271£681,300
4/19/2016Darwazah,SaidInsiderBuy30,000GBX 2,266£679,800
4/11/2016J. Castellani,JohnInsiderBuy2,500GBX 2,103£52,575
4/7/2016Darwazah,MazenInsiderBuy60,000GBX 2,118£1,270,800
4/5/2016Darwazah,SaidInsiderBuy30,000GBX 2,055£616,500
3/31/2016Darwazah,SaidInsiderBuy30,000GBX 1,972£591,600
3/24/2016Butler,PatInsiderBuy2,500GBX 1,920£48,000
3/21/2016Pickering ,RobertInsiderBuy2,500GBX 1,856£46,400
8/27/2015Kirby,PamelaInsiderBuy3,317GBX 2,264£75,096.88
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Hikma Pharmaceuticals PLC (LON HIK)

Source:
DateHeadline
Hikma buys 6 Boehringer products in $3.5 mln deal - MarketWatchHikma buys 6 Boehringer products in $3.5 mln deal - MarketWatch
www.marketwatch.com - November 16 at 9:40 PM
Hikma buys 6 Boehringer products in $3.5 mln dealHikma buys 6 Boehringer products in $3.5 mln deal
www.marketwatch.com - November 14 at 5:33 AM
West-Ward Columbus taking on pill manufacturing from New Jersey sister plantWest-Ward Columbus taking on pill manufacturing from New Jersey sister plant
www.bizjournals.com - November 13 at 7:29 PM
Hikma Pharmaceuticals Plc (HIK) PT Lowered to GBX 1,000 at J P Morgan Chase & CoHikma Pharmaceuticals Plc (HIK) PT Lowered to GBX 1,000 at J P Morgan Chase & Co
www.americanbankingnews.com - November 12 at 8:34 PM
Numis Securities Ltd Upgrades Hikma Pharmaceuticals Plc (HIK) to BuyNumis Securities Ltd Upgrades Hikma Pharmaceuticals Plc (HIK) to Buy
www.americanbankingnews.com - November 9 at 7:58 AM
Hikma Pharmaceuticals Plc (HIK) PT Lowered to GBX 1,000Hikma Pharmaceuticals Plc (HIK) PT Lowered to GBX 1,000
www.americanbankingnews.com - November 9 at 7:58 AM
TOP NEWS: Hikma Cuts View, Pursues Dispute With FDA On Generic AdvairTOP NEWS: Hikma Cuts View, Pursues Dispute With FDA On Generic Advair
www.morningstar.co.uk - November 9 at 6:40 AM
Hikma cuts guidance on generics unit for 3rd timeHikma cuts guidance on generics unit for 3rd time
www.marketwatch.com - November 9 at 6:40 AM
Hikma Pharma Backs FY17 Revenue View, Cuts Forecast For Generics; Stock DownHikma Pharma Backs FY17 Revenue View, Cuts Forecast For Generics; Stock Down
www.rttnews.com - November 9 at 6:40 AM
UPDATE 1-UK Stocks-Factors to watch on Nov 9 - ReutersUPDATE 1-UK Stocks-Factors to watch on Nov 9 - Reuters
www.reuters.com - November 9 at 6:39 AM
UPDATE 1-Hikma in dispute with FDA over generic Advair, cuts generics sales forecast again - ReutersUPDATE 1-Hikma in dispute with FDA over generic Advair, cuts generics sales forecast again - Reuters
www.reuters.com - November 9 at 6:39 AM
FTSE under pressure as Burberry revamps its strategyFTSE under pressure as Burberry revamps its strategy
finance.yahoo.com - November 9 at 6:39 AM
Hikma Pharmaceuticals Plc (HIK) Given Consensus Recommendation of "Hold" by AnalystsHikma Pharmaceuticals Plc (HIK) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - November 5 at 6:22 AM
Hikma Pharmaceuticals Launches Flucytosine Capsules In USHikma Pharmaceuticals Launches Flucytosine Capsules In US
www.morningstar.co.uk - November 4 at 4:41 AM
Hikma US unit launches heartburn drug - MarketWatchHikma US unit launches heartburn drug - MarketWatch
www.marketwatch.com - November 2 at 12:13 AM
Why Hikma Pharmaceuticals PLC’s (LSE:HIK) ROE Of 6.97% Does Not Tell The Whole StoryWhy Hikma Pharmaceuticals PLC’s (LSE:HIK) ROE Of 6.97% Does Not Tell The Whole Story
finance.yahoo.com - November 2 at 12:13 AM
Why I’d buy this FTSE 250 stock alongside AstraZeneca plcWhy I’d buy this FTSE 250 stock alongside AstraZeneca plc
www.fool.co.uk - October 30 at 3:33 PM
Hikma U.S. unit launches heartburn drugHikma U.S. unit launches heartburn drug
www.marketwatch.com - October 30 at 3:33 PM
BRIEF-Hikma says US unit launched pantoprazole sodium for injectionBRIEF-Hikma says US unit launched pantoprazole sodium for injection
www.reuters.com - October 30 at 3:33 PM
Hikma Pharmaceuticals Plc – Value Analysis (LONDON:HIK) : October 25, 2017Hikma Pharmaceuticals Plc – Value Analysis (LONDON:HIK) : October 25, 2017
finance.yahoo.com - October 26 at 10:51 AM
Hikma Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : HIK-GB : October 24, 2017Hikma Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : HIK-GB : October 24, 2017
finance.yahoo.com - October 25 at 3:39 AM
Have Investors Already Priced In Hikma Pharmaceuticals PLC’s (LSE:HIK) Growth?Have Investors Already Priced In Hikma Pharmaceuticals PLC’s (LSE:HIK) Growth?
finance.yahoo.com - October 19 at 2:07 AM
ETFs with exposure to Hikma Pharmaceuticals Plc : October 17, 2017ETFs with exposure to Hikma Pharmaceuticals Plc : October 17, 2017
finance.yahoo.com - October 17 at 8:09 PM
Hikma Pharmaceuticals Plc (HIK) Given Consensus Rating of "Hold" by AnalystsHikma Pharmaceuticals Plc (HIK) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - October 11 at 6:28 AM
Hikma Pharmaceuticals Plc (HIK) Price Target Lowered to GBX 1,250 at J P Morgan Chase & CoHikma Pharmaceuticals Plc (HIK) Price Target Lowered to GBX 1,250 at J P Morgan Chase & Co
www.americanbankingnews.com - October 7 at 8:02 PM
Should You Be Tempted To Buy Hikma Pharmaceuticals PLC (LSE:HIK) Because Of Its PE Ratio?Should You Be Tempted To Buy Hikma Pharmaceuticals PLC (LSE:HIK) Because Of Its PE Ratio?
finance.yahoo.com - October 3 at 9:45 AM
Hikma Pharmaceuticals Plc (HIK) Stock Rating Reaffirmed by J P Morgan Chase & CoHikma Pharmaceuticals Plc (HIK) Stock Rating Reaffirmed by J P Morgan Chase & Co
www.americanbankingnews.com - September 29 at 8:34 PM
Hikma Pharmaceuticals Plc (HIK) Given Average Rating of "Hold" by BrokeragesHikma Pharmaceuticals Plc (HIK) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 16 at 6:56 AM
EXTRA: Vectura Posts Pretax Loss Increase Due To Amortisation CostsEXTRA: Vectura Posts Pretax Loss Increase Due To Amortisation Costs
www.morningstar.co.uk - September 6 at 7:23 PM
ETFs with exposure to Hikma Pharmaceuticals Plc : August 29, 2017ETFs with exposure to Hikma Pharmaceuticals Plc : August 29, 2017
finance.yahoo.com - August 29 at 8:00 PM
Hikma Pharmaceuticals Plc (HIK) Downgraded by Stifel NicolausHikma Pharmaceuticals Plc (HIK) Downgraded by Stifel Nicolaus
www.americanbankingnews.com - August 29 at 6:38 AM
Hikma Pharmaceuticals Plcs (HIK) "Neutral" Rating Reaffirmed at Citigroup Inc.Hikma Pharmaceuticals Plc's (HIK) "Neutral" Rating Reaffirmed at Citigroup Inc.
www.americanbankingnews.com - August 28 at 12:56 AM
Hikma Pharmaceuticals Plc (HIK) Price Target Lowered to GBX 1,500 at Barclays PLCHikma Pharmaceuticals Plc (HIK) Price Target Lowered to GBX 1,500 at Barclays PLC
www.americanbankingnews.com - August 27 at 8:50 AM
[$$] Drug stocks shine as FTSE 100 drifts lower[$$] Drug stocks shine as FTSE 100 drifts lower
finance.yahoo.com - August 26 at 5:25 AM
Hikma Pharmaceuticals Plc : HIK-GB: Dividend Analysis : August 25th, 2017 (record date) : By the numbers : August 26, 2017Hikma Pharmaceuticals Plc : HIK-GB: Dividend Analysis : August 25th, 2017 (record date) : By the numbers : August 26, 2017
finance.yahoo.com - August 26 at 5:25 AM
Propeller Health Announces Expansion of Digital Health Collaboration with GlaxoSmithKline to Improve Management of Asthma and COPDPropeller Health Announces Expansion of Digital Health Collaboration with GlaxoSmithKline to Improve Management of Asthma and COPD
finance.yahoo.com - August 24 at 7:28 AM
UK Stocks-Factors to watch on Aug 21 - ReutersUK Stocks-Factors to watch on Aug 21 - Reuters
www.reuters.com - August 22 at 9:07 PM
Hikma Pharmaceuticals Plc :HIK-GB: Earnings Analysis: For the six months ended June 30, 2017 : August 22, 2017Hikma Pharmaceuticals Plc :HIK-GB: Earnings Analysis: For the six months ended June 30, 2017 : August 22, 2017
finance.yahoo.com - August 22 at 9:07 PM
Hikma Pharmaceuticals Plc (HIK) Given Consensus Recommendation of "Hold" by BrokeragesHikma Pharmaceuticals Plc (HIK) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - August 22 at 6:44 AM
Jazz on the Street: Analysts’ Recommendations for JAZZ in AugustJazz on the Street: Analysts’ Recommendations for JAZZ in August
finance.yahoo.com - August 21 at 6:45 PM
[$$] Imperial sighs after broker waves away vaping scepticism[$$] Imperial sighs after broker waves away vaping scepticism
finance.yahoo.com - August 21 at 6:45 PM
Hikma Pharmaceuticals Plc (HIK) Price Target Lowered to GBX 1,045 at Jefferies Group LLCHikma Pharmaceuticals Plc (HIK) Price Target Lowered to GBX 1,045 at Jefferies Group LLC
www.americanbankingnews.com - August 21 at 4:46 PM
Morgan Stanley Lowers Hikma Pharmaceuticals Plc (HIK) to Equal weightMorgan Stanley Lowers Hikma Pharmaceuticals Plc (HIK) to Equal weight
www.americanbankingnews.com - August 21 at 6:06 AM
Drugmaker Hikmas US unit raises medicine prices: Financial Times - ReutersDrugmaker Hikma's US unit raises medicine prices: Financial Times - Reuters
www.reuters.com - August 20 at 5:48 PM
Hikma Pharmaceuticals Plc (HIK) Earns "Hold" Rating from Peel HuntHikma Pharmaceuticals Plc (HIK) Earns "Hold" Rating from Peel Hunt
www.americanbankingnews.com - August 20 at 5:02 PM
Hikma Pharmaceuticals Plc (HIK) Stock Rating Reaffirmed by Numis Securities LtdHikma Pharmaceuticals Plc (HIK) Stock Rating Reaffirmed by Numis Securities Ltd
www.americanbankingnews.com - August 20 at 3:44 PM
Hikma sees tough competition in generics marketHikma sees tough competition in generics market
www.marketwatch.com - August 18 at 7:17 PM
Hikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gainHikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gain
www.fool.co.uk - August 18 at 7:17 PM
Hikma Pharmaceuticals plc. 2017 Q2 - Results - Earnings Call SlidesHikma Pharmaceuticals plc. 2017 Q2 - Results - Earnings Call Slides
seekingalpha.com - August 18 at 7:17 PM
UPDATE 1-UK Stocks-Factors to watch on Aug 17 - Business InsiderUPDATE 1-UK Stocks-Factors to watch on Aug 17 - Business Insider
www.businessinsider.com - August 18 at 4:02 AM

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Hikma Pharmaceuticals PLC (LON HIK) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.